Company Data

Vaccinex Inc.

Ticker
VCNX
Current Price
$1.03 -8.04%
Market Cap
$2.7M
Price Target
Refer to Report
Volume
1.3K
52wk Range
$0.76 - $10.1
Advanced Market Data

Overview

Vaccinex Inc is a clinical-stage biotechnology company. It is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company’s product pipeline includes pepinemab (VX15), which targets Huntington’s Disease (HD) and non-small cell lung cancer (NSCLC) and also neurodegenerative disorders; VX5 Autoimmune for the treatment of MS and potentially for other autoimmune disorder; and others.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy